Our partnerships with leading global pharmaceutical and biotechnological companies are bringing life-changing medicines to patients in emerging markets.
In-licensing is a priority business for Raifarm. Access to the best modern medicines can transform patients’ lives, while manufacturers gain access to vital new revenue streams, enabling them to capitalize more fully on their R&D investments.
In return for exclusive product rights, we register and market new products, enabling successful commercialization. Our partners work with us because of our in-depth knowledge and understanding of local markets, operational efficiency, clear business strategy, and Western approach to ethics and transparency.
We are keen to partner with leading producers from all over the world. While our primary focus is on original and innovative products, we are happy to consider any collaboration proposal in the sector.